Share on LinkedInShare on LinkedIn

ARTICLE · 09 APRIL 2012

Conditional Clearance For Polpharma/Polfa Takeover

Zakłady Farmaceutyczne Polpharma has received conditional clearance to take over Polfa Warszawa from the President of Poland’s Competition Authority, UOKiK.

PolandAntitrust/Competition Law
Malgorzata Urbańska
Malgorzata Urbańska
Mikolaj Piaskowski
Mikolaj Piaskowski

Zakłady Farmaceutyczne Polpharma has received conditional clearance to take over Polfa Warszawa from the President of Poland's Competition Authority, UOKiK.

Polpharma is a subsidiary of Genefar. Polfa Warszawa is a state-owned company belonging to Polski Holding Farmaceutyczny. Both produce and sell pharmaceuticals.

UOKiK concluded that the takeover would affect competition in three markets:

  • It would give Polpharma a dominant share (significantly above the 40% threshold) of the markets for non-prescription anti-thrombotic drugs (for people with heart problems) and for prescription fluorochinolones (general use antibiotics)
  • It would give Polpharma a monopoly over the market for prescription sulfonamids (for treating bacterial eye infections)

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from